Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. LAL PATHLABS Plunges 4%; BSE HEALTHCARE Index Up 0.4%
Thu, 24 Oct 11:12

DR. LAL PATHLABS Plunges 4%; BSE HEALTHCARE Index Up 0.4%Image source: KanawatTH/www.istockphoto.com

DR. LAL PATHLABS share price has plunged 4% and is presently trading at Rs 3,111.7.

Meanwhile, the BSE HEALTHCARE index is at 42,870.5 (up 0.4%).

Among the top losers in the BSE HEALTHCARE index today are MAX HEALTHCARE INSTITUTE (down 1.7%) and Pfizer (down 1.6%).

ASTER DM HEALTHCARE (up 7.5%) and SYNGENE INTERNATIONAL (up 6.7%) are among the top gainers today.

Over the last one year, DR. LAL PATHLABS has moved up from Rs 2,439.9 to Rs 3,111.7, registering a gain of Rs 671.9 (up 27.5%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,503.7 to 42,870.5, registering a gain of 55.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 215.4%), Glenmark Pharma (up 122.7%) and SUVEN PHARMACEUTICALS (up 120.5%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,041.5 (down 0.1%).

The top losers among the BSE Sensex today are Hindustan Unilever (down 6.7%) and Nestle (down 2.2%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.

In the meantime, NSE Nifty is at 24,398.5 (down 0.2%). Hindustan Unilever and SBI LIFE INSURANCE are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 80,041.5, registering a gain of 15,469.6 points (up 24.0%).

DR. LAL PATHLABS Financial Update...

DR. LAL PATHLABS net profit grew 18.2% YoY to Rs 1,308 million for the quarter ended September 2024, compared to a profit of Rs 1,107 million a year ago. Net sales rose 9.8% to Rs 6,602 million during the period as against Rs 6,013 million in July-September 2023.

For the year ended March 2024, DR. LAL PATHLABS reported 50.3% increase in net profit to Rs 3,623 million compared to net profit of Rs 2,411 million during FY23. Revenue of the company grew 10.4% to Rs 22,266 million during FY24.

The current Price to earnings ratio of DR. LAL PATHLABS, based on rolling 12 month earnings, stands at 64.0.


Equitymaster requests your view! Post a comment on "DR. LAL PATHLABS Plunges 4%; BSE HEALTHCARE Index Up 0.4%". Click here!